RILEY SANTOS-READ: Open Payments
NPI 1841864972 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 19 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $203 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $434 |
| ViiV Healthcare Company | 5 | $170 |
| Lilly USA, LLC | 2 | $47 |
| EMD Serono, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: APRETUDE, Yeztugo, CABENUVA, MOUNJARO, SHINGRIX, M-M-R II.
Industry payments across CA — which companies pay providers there.
